arah Morgan, March 05, 2020, 8:00 AM Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B drug Alprolix (coagulation factor IX (Recombinant), Fc fusion protein). In its suit, filed yesterday, March 4, at the US District Court for the District of Delawa